Biomarker Development/Validation (2021)
קרן | ALS Association |
---|---|
מדינה | U.S.A. |
סוג | Research Grants |
תאריך אחרון | 07/05/2021 |
פקולטה | Life Sciences, Medicine |
תיאור | This RFA aims to support the discovery and/or validation of biomarkers for ALS or a related disorder (including primary lateral sclerosis [PLS], hereditary spastic paraplegia [HSP], progressive muscular atrophy [PMA], multisystem proteinopathy [MSP], and frontotemporal dementia [FTD]). Priority will be given to those projects that are focused on developing biomarkers of disease mechanism and that might be relevant to the development of therapies.
Funding: $60,000 total Duration: 1 year
Research Authority due date: 29.4.21 LOI (required) due date: 7.5.21 Full proposal due date: 30.7.21 |
קבצים מצורפים | |
קישור | לאתר |
עדכון אחרון | עדכון אחרון: 13/04/2021 |